Approach to a multiparametric sensor-chip-based tumor chemosensitivity assay.

Area of Science:

• Biomedical Engineering
• Oncology
• Translational Medicine

Background:

• In vitro tumor chemosensitivity assays (TCA) can improve cancer patient survival by guiding personalized therapy.
• Current TCA methods often rely on empirically retrieved data, potentially leading to inadequate chemotherapy.
• Individualized cancer treatment decisions can be supported by accurate chemosensitivity testing.

Purpose of the Study:

• To present the initial results of a novel sensor-chip-based technology for multiparametric TCA.
• To evaluate the potential of dynamic, on-line data generation for assessing tumor chemosensitivity.
• To compare the performance of sensor chip technology with existing assay methods.

Main Methods:

• Development and application of miniaturized silicon and glass sensor chips for cell cultures and human tumor explants.
• On-line monitoring of metabolic profiles, including extracellular acidification and cellular oxygen consumption.
• Assessment of cellular morphology changes via electric impedance monitoring.

Main Results:

• Drug-associated cellular signals were detected using all three parameters (metabolic and impedance) in cell lines.
• Primary tumor explants exhibited metabolic responses to drugs, but not impedance changes.
• Cellular respiration and mitochondrial activity emerged as sensitive indicators of acute cytotoxic effects.

Conclusions:

• Sensor chip technology shows promise for multiparametric TCA, offering dynamic, on-line data acquisition.
• Metabolic profiling, particularly cellular respiration, appears highly sensitive to cytotoxic drug effects in tumor explants.
• Further development is needed to address current challenges and fully realize the potential of sensor chip technology in clinical TCA.